Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Orion Laboratories Pty Ltd T/A Perrigo Australia

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (279)
ARTG (50)
Cancellation or suspension (26)
COVID-19 disinfectant (4)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine registration (1)

Date

2024 (10)
2023 (22)
2022 (32)
2021 (14)
2020 (13)
2019 (91)
2018 (21)
2017 (40)
2016 (1)
2015 (76)
2014 (1)
2013 (1)
2009 (3)
2008 (5)
2007 (2)
1992 (3)
1991 (23)

Results for "[search-keyword]"

Search

Sponsor content

362 result(s) found, displaying 51 to 60

YOUR PHARMACY NASAL CONGESTION RELIEF phenylephrine hydrochloride 12.2mg capsule blister pack. Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
HERRON PARACETAMOL GOLD CAPSEALS 500mg gelatin coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
HERRON PARACETAMOL GOLD CAPSEALS 500mg gelatin coated tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
QUELLADA SCABIES TREATMENT LOTION permethrin 50mg/mL bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
ORION CALAMINE LOTION BP calamine 15% w/v lotion bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
ALCOHOLIC IODINE SOLUTION BP solution bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
SENEGAR Senega and Ammonia mixture oral liquid bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
PHARMACY DIRECT CETIRIZINE 10mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
YOUR PHARMACY CETIRIZINE 10mg tablets bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
MEDIHEALTH CETIRIZINE 10mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.